All Stories

  1. Manganese(II) Complexes with 3,5–Dibromosalicylaldehyde: Characterization and Interaction Studies with DNA and Albumins
  2. Synthesis, Characterization and Biological Profile of Cationic Cobalt Complexes with First-Generation Quinolones
  3. Iron(III) Complexes with Substituted Salicylaldehydes: Synthesis, Interaction with DNA and Serum Albumins, and Antioxidant Activity
  4. Manganese(II) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure and Biological Activity
  5. Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria
  6. Novel Tricarbonylrhenium-Anthrapyrazole Complexes with DNA-Binding and Antitumor Properties: In Vitro and In Vivo Pharmacokinetic Studies with 99mTc-Analogue
  7. One-Pot, Multi-Component Green Microwave-Assisted Synthesis of Bridgehead Bicyclo[4.4.0]boron Heterocycles and DNA Affinity Studies
  8. Erbium(III) complexes with fluoroquinolones: Structure and biological properties
  9. Coordination Compounds of Nickel(II) with 3,5–Dibromo–Salicylaldehyde: Structure and Interaction with Biomolecules
  10. Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
  11. Cu(ii) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach
  12. Coordination compounds of cobalt(ii) with carboxylate non-steroidal anti-inflammatory drugs: structure and biological profile
  13. Neutral and cationic nickel(II) complexes with substituted salicylaldehydes: Characterization, antibacterial activity, and interaction with biomacromolecules
  14. Transition metal(II) complexes with the non–steroidal anti–inflammatory drug oxaprozin: Characterization and biological profile
  15. Erbium(III) coordination compounds with substituted salicylaldehydes: Characterization and biological profile
  16. pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
  17. Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules
  18. Metal Complexes with Naphthalene-Based Acetic Acids as Ligands: Structure and Biological Activity
  19. Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells
  20. Copper(II) complexes with 3,5–dihalogeno–salicylaldehydes: Synthesis, structure and interaction with DNA and albumins
  21. Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide
  22. Copper(II) Complexes of 5–Fluoro–Salicylaldehyde: Synthesis, Characterization, Antioxidant Properties, Interaction with DNA and Serum Albumins
  23. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins
  24. Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile
  25. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
  26. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  27. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5–dichloro–salicylaldehyde
  28. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity
  29. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
  30. Manganese(II) complexes of substituted salicylaldehydes and α-diimines: Synthesis, characterization and biological activity
  31. Zinc(II) complexes of 3,5–dibromo–salicylaldehyde and α–diimines: Synthesis, characterization and in vitro and in silico biological profile
  32. Stimuli-responsive spin crossover nanoparticles for drug delivery and DNA-binding studies
  33. Zinc(ii) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity
  34. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin andin silicostudies
  35. Silver(i) complexes bearing heterocyclic thioamide ligands with NH2 and CF3 substituents: effect of ligand group substitution on antibacterial and anticancer properties
  36. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile
  37. Synthesis, characterization and (in vitro and in silico) biological activity of a series of dioxouranium(VI) complexes with non-steroidal anti-inflammatory drugs
  38. Nickel(II)–meclofenamate complexes: Structure, in vitro and in silico DNA– and albumin–binding studies, antioxidant and anticholinergic activity
  39. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline
  40. Trinuclear and tetranuclear iron(III) complexes with fenamates: Structure and biological profile
  41. Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity
  42. Interaction of manganese(II) with the hybrid molecule (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: Structure and biological profile
  43. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  44. Facile Method to Prepare pH-Sensitive PEI-Functionalized Carbon Nanotubes as Rationally Designed Vehicles for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery
  45. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin
  46. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA
  47. Structure and biological evaluation of pyridine-2-carboxamidine copper(II) complex resulting from N′-(4-nitrophenylsulfonyloxy)2-pyridine-carboxamidoxime
  48. Copper(II) and zinc(II) coordination compounds of non-steroidal anti-inflammatory drugs: Structural features and antioxidant activity
  49. Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity
  50. p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies
  51. Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs
  52. Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
  53. A palladium(II) complex with the Schiff base 4-chloro-2-(N-ethyliminomethyl)-phenol: Synthesis, structural characterization, and in vitro and in silico biological activity studies
  54. Bi- and trinuclear copper(I) compounds of 2,2,5,5-tetramethyl-imidazolidine-4-thione and 1,2-bis(diphenylphosphano)ethane: Synthesis, crystal structures, in vitro and in silico study of antibacterial activity and interaction with DNA and albumins
  55. Cobalt(II) complexes with the non-steroidal anti-inflammatory drug diclofenac and nitrogen-donor ligands
  56. Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin
  57. Zinc-oxaprozin compounds: Synthesis, structure and biological activity
  58. Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
  59. Organometallic rhenium tricarbonyl–enrofloxacin and –levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies
  60. Palladium(II) complexes with salicylaldehyde ligands: Synthesis, characterization, structure, in vitro and in silico study of the interaction with calf-thymus DNA and albumins
  61. Manganese coordination compounds of mefenamic acid: In vitro screening and in silico prediction of biological activity
  62. Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
  63. Copper(II) diclofenac complexes: Synthesis, structural studies and interaction with albumins and calf-thymus DNA
  64. Heterocyclic thioamide/phosphine mixed-ligand silver(I) complexes: Synthesis, molecular structures, DNA-binding properties and antibacterial activity
  65. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  66. A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity
  67. Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity
  68. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  69. Manganese(ii) complexes with the non-steroidal anti-inflammatory drugs naproxen and mefenamic acid: synthesis, structure, antioxidant capacity, and interaction with albumins and DNA
  70. Nickel(II)-indomethacin mixed-ligand complexes: Synthesis, characterization, antioxidant activity and interaction with DNA and albumins
  71. Interaction of zinc(II) with the non-steroidal anti-inflammatory drug niflumic acid
  72. Toward Multifunctional Materials Incorporating Stepladder Manganese(III) Inverse-[9-MC-3]-Metallacrowns and Anti-Inflammatory Drugs
  73. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins
  74. Synthesis, structural, thermal characterization and interaction with calf-thymus DNA and albumins of cationic Ni(II) complexes with 2,2′-dipyridylamine and salicylaldehydes
  75. Nickel(ii)–naproxen mixed-ligand complexes: synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  76. Copper(I) halide complexes of 2,2,5,5-tetramethyl-imidazolidine-4-thione: Synthesis, structures, luminescence, thermal stability and interaction with DNA
  77. Copper(II) complexes with gatifloxacin
  78. Zinc complexes of flufenamic acid: Characterization and biological evaluation
  79. Ni(II) complexes with 2,2-dipyridylamine and salicylaldehydes: Synthesis, crystal structure and interaction with calf-thymus DNA and albumins
  80. Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
  81. Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  82. Cobalt(II) complexes of sparfloxacin
  83. Nickel-diflunisal complexes: synthesis, characterization, in vitro antioxidant activity and interaction with DNA and albumins
  84. Characterization and biological properties of copper(II)-ketoprofen complexes
  85. Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis, structures, antibacterial activity and DNA interaction
  86. Co-NSAIDs
  87. Synthesis, characterization and biological evaluation of 99m Tc/Re–tricarbonyl quinolone complexes
  88. Pyridine and p-Nitrophenyl Oxime Esters with Possible Photochemotherapeutic Activity: Synthesis, DNA Photocleavage and DNA Binding Studies
  89. Alkyl and aryl sulfonyl p-pyridine ethanone oximes are efficient DNA photo-cleavage agents
  90. Cd - 5-Cl-saloH
  91. Cd - 5-Br-saloH
  92. Evaluation of O-alkyl and aryl sulfonyl aromatic and heteroaromatic amidoximes as novel potent DNA photo-cleavers
  93. Structure and biological activities of metal complexes of flumequine
  94. New copper(ii) complexes of the anti-inflammatory drug mefenamic acid: a concerted study including synthesis, physicochemical characterization and their biological evaluation
  95. On the Complexity of Dynamic Mechanism Design
  96. Copper(II) Inverse-[9-Metallacrown-3] Compounds Accommodating ­Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity
  97. Cd - 5-nitro-saloH
  98. Mn-diclofenac complexes
  99. Copper-tolfenamato complexes
  100. Mn3-diclofenac
  101. Ni - mefanamato complexes
  102. Manganese(II)–sparfloxacinato complexes
  103. Cobalt-oxolinato complexes
  104. Cu - saloH
  105. Copper(II)–indomethacin complexes
  106. Thermal analysis and structural characterization of copper(II) complexes with salicyladehydes
  107. Cobalt(II) complexes of enrofloxacin
  108. Synthesis, thermal analysis, and spectroscopic and structural characterizations of tetranuclear nickel(II) cubane-type clusters with 2-hydroxybenzaldehydes or 2-hydroxyphenones
  109. Synthesis, characterization, thermal and DNA-binding properties of new zinc complexes with 2-hydroxyphenones
  110. Zinc-tolfenamato
  111. Manganese(II) complexes of tolfenamic acid
  112. Zinc complexes of mefenamic acid
  113. Zn saloH
  114. Nickel complexes of diclofenac
  115. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  116. Copper(II) complexes of flufenamic acid
  117. Manganese(II) complexes of niflumic acid
  118. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  119. Manganese(II) complexes of oxolinic acid and enrofloxacin
  120. Metal complexes of quinolones or NSAIDs: Perspective
  121. Zinc complexes of flumequine
  122. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  123. Copper(II) complexes of flumequine
  124. A [24-MC-6] Zinc Metallacoronate with a Nonsteroidal Antiinflammatory Drug as the Constructing Ligand
  125. First Palladium(II) and Platinum(II) Complexes from Employment of 2,6-Diacetylpyridine Dioxime: Synthesis, Structural and Spectroscopic Characterization, and Biological Evaluation
  126. Cobalt(II)-tolfenamato complexes
  127. Cobalt - naproxen
  128. Zinc complexes of tolfenamic acid
  129. Copper - diflunisal
  130. Nickel–quinolones-bipyam complexes
  131. Copper(II) complexes of naproxen / diclofenac
  132. Copper(ii) complexes of mefenamic acid
  133. Zinc complexes of sparfoxacin - levofloxacin
  134. Nickel complexes of enrofloxacin
  135. Nickel complexes of flumequine
  136. Metal - sparfloxacin complexes
  137. Zinc(II) complexes of enrofloxacin
  138. Nickel complexes of oxolinic acid
  139. Cobalt(ii) complexes of mefenamic acid
  140. Nickel complexes of sparfloxacin
  141. Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
  142. Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex
  143. Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]
  144. Zinc-oxolinato complexes
  145. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties
  146. Magnesium complexes of ciprofloxacin
  147. Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)–sparfloxacin complex
  148. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  149. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure–activity relationship
  150. Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  151. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
  152. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  153. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA
  154. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation
  155. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
  156. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity
  157. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
  158. Metal-pipemidato complexes
  159. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine
  160. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid
  161. Copper-enrofloxacin complexes
  162. Cu(II) - sparfloxacin
  163. Metal-piroxicam complexes
  164. An Unprecedented Trinuclear Structure Involving Two High-Spin and One Spin-Crossover Iron(II) Centers
  165. Host-Guest Interaction of 12-MC-4, 15-MC-5, and Fused 12-MC-4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior
  166. Preparation of Site-Differentiated Mixed Ligand and Mixed Ligand/Mixed Metal Metallacrowns
  167. Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity
  168. Structurally Diverse Copper(II)−Carboxylato Complexes:  Neutral and Ionic Mononuclear Structures and a Novel Binuclear Structure
  169. Ni metallacrowns hosting a carboxylic herbicide
  170. CuII-herbicide complexes: structure and bioactivity
  171. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes
  172. Mn(II) - MCPA